JP2009511892A5 - - Google Patents

Download PDF

Info

Publication number
JP2009511892A5
JP2009511892A5 JP2008535094A JP2008535094A JP2009511892A5 JP 2009511892 A5 JP2009511892 A5 JP 2009511892A5 JP 2008535094 A JP2008535094 A JP 2008535094A JP 2008535094 A JP2008535094 A JP 2008535094A JP 2009511892 A5 JP2009511892 A5 JP 2009511892A5
Authority
JP
Japan
Prior art keywords
variable domain
chain variable
antibody
heavy chain
light chain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008535094A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009511892A (ja
Filing date
Publication date
Priority claimed from GB0520644A external-priority patent/GB0520644D0/en
Priority claimed from GB0521140A external-priority patent/GB0521140D0/en
Application filed filed Critical
Priority claimed from PCT/GB2006/003781 external-priority patent/WO2007042809A2/en
Publication of JP2009511892A publication Critical patent/JP2009511892A/ja
Publication of JP2009511892A5 publication Critical patent/JP2009511892A5/ja
Pending legal-status Critical Current

Links

JP2008535094A 2005-10-11 2006-10-11 抗体ポリペプチドライブラリーのスクリーニングと選択された抗体ポリペプチド Pending JP2009511892A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0520644A GB0520644D0 (en) 2005-10-11 2005-10-11 Antibody polypeptide library screening and selected antibody polypeptides
GB0521140A GB0521140D0 (en) 2005-10-18 2005-10-18 Antibody polypeptide library screening and selected antibody polypeptides
PCT/GB2006/003781 WO2007042809A2 (en) 2005-10-11 2006-10-11 Antibody polypeptide library screening and selected antibody polypeptides

Publications (2)

Publication Number Publication Date
JP2009511892A JP2009511892A (ja) 2009-03-19
JP2009511892A5 true JP2009511892A5 (https=) 2009-10-22

Family

ID=37943170

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008535094A Pending JP2009511892A (ja) 2005-10-11 2006-10-11 抗体ポリペプチドライブラリーのスクリーニングと選択された抗体ポリペプチド

Country Status (6)

Country Link
US (1) US20100168393A1 (https=)
EP (1) EP1951754A2 (https=)
JP (1) JP2009511892A (https=)
AU (1) AU2006300951A1 (https=)
CA (1) CA2625222A1 (https=)
WO (1) WO2007042809A2 (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7981420B2 (en) 2000-12-22 2011-07-19 Max-Planck-Gesellschaft Zur Foederung Der Wissenschaften E.V. Therapeutic use of antibodies directed against repulsive guidance molecule (RGM)
EP1928905B1 (de) 2005-09-30 2015-04-15 AbbVie Deutschland GmbH & Co KG Bindungsdomänen von proteinen der repulsive guidance molecule (rgm) proteinfamilie und funktionale fragmente davon sowie deren verwendung
US8962803B2 (en) 2008-02-29 2015-02-24 AbbVie Deutschland GmbH & Co. KG Antibodies against the RGM A protein and uses thereof
AU2020201002B2 (en) * 2008-06-25 2022-04-07 Novartis Ag Humanization of rabbit antibodies using a universal antibody framework
PL2307458T3 (pl) * 2008-06-25 2018-08-31 Esbatech, An Alcon Biomedical Research Unit Llc Humanizacja przeciwciał króliczych z zastosowaniem uniwersalnego zrębu przeciwciała
KR102050040B1 (ko) 2008-06-25 2019-11-28 에스바테크 - 어 노바티스 컴파니 엘엘씨 TNFα를 저해하는 안정한 가용성 항체
MX2012006560A (es) 2009-12-08 2012-10-05 Abbott Gmbh & Co Kg Anticuerpos monoclonales contra la proteina rgm a para utilizarse en el tratamiento de degeneracion de capa de fibra de nervio retinal.
WO2011102342A1 (ja) 2010-02-16 2011-08-25 国立大学法人京都工芸繊維大学 抗体固定化担体、抗体固定化担体の製造方法および当該抗体固定化担体の利用
CN103261220B (zh) * 2010-08-16 2016-06-15 诺夫免疫股份有限公司 用于生成多特异性和多价抗体的方法
UY33679A (es) 2010-10-22 2012-03-30 Esbatech Anticuerpos estables y solubles
EP2670779B1 (en) * 2011-02-01 2017-08-02 Bac Ip B.V. Antigen-binding protein directed against epitope in the ch1 domain of human igg antibodies
EP3369746A1 (en) 2012-01-27 2018-09-05 AbbVie Deutschland GmbH & Co KG Composition and method for diagnosis and treatment of diseases associated with neurite degeneration
CN107814845B (zh) * 2016-09-14 2021-02-09 浙江特瑞思药业股份有限公司 新的抗pd-1纳米抗体及其应用
CN107857816B (zh) * 2017-10-17 2020-11-06 北京大学 一种抗干扰素α-2b纳米抗体及其应用
US12247060B2 (en) 2018-01-09 2025-03-11 Marengo Therapeutics, Inc. Calreticulin binding constructs and engineered T cells for the treatment of diseases
EP3765517A1 (en) 2018-03-14 2021-01-20 Elstar Therapeutics, Inc. Multifunctional molecules that bind to calreticulin and uses thereof
CA3105448A1 (en) 2018-07-03 2020-01-09 Elstar Therapeutics, Inc. Anti-tcr antibody molecules and uses thereof
GB2595980B (en) * 2019-01-04 2023-06-14 Marengo Therapeutics Inc Anti-TCR antibody molecules and uses thereof
CN119039441A (zh) 2019-02-21 2024-11-29 马伦戈治疗公司 与nkp30结合的抗体分子及其用途
GB2599228B (en) 2019-02-21 2024-02-07 Marengo Therapeutics Inc Multifunctional molecules that bind to T cell related cancer cells and uses thereof
AU2020416273A1 (en) 2020-01-03 2022-07-28 Marengo Therapeutics, Inc. Anti-TCR antibody molecules and uses thereof
AU2022298665A1 (en) * 2021-06-22 2024-01-04 University Of Virginia Patent Foundation Compositions and methods for detecting and regulating fibronectin-integrin interactions and signaling
CN116239687B (zh) * 2021-12-22 2026-03-24 北京世纪沃德生物科技有限公司 一种crp驼源单域抗体及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5565332A (en) * 1991-09-23 1996-10-15 Medical Research Council Production of chimeric antibodies - a combinatorial approach
GB9722131D0 (en) * 1997-10-20 1997-12-17 Medical Res Council Method
ZA9811162B (en) * 1997-12-12 2000-06-07 Genentech Inc Treatment with anti-ERBB2 antibodies.
WO2004016782A1 (ja) * 2002-08-16 2004-02-26 The University Of Tokyo 複数の蛋白質の間の相互作用を測定する方法
US8337841B2 (en) * 2003-01-21 2012-12-25 Chugai Seiyaku Kabushiki Kaisha Methods of screening for antibody light chains
WO2005058251A2 (en) * 2003-12-15 2005-06-30 Dendreon Corporation Hla-dr-specific antibodies, compositions and methods

Similar Documents

Publication Publication Date Title
JP2009511892A5 (https=)
JP7676474B2 (ja) Cd47およびpd-l1に特異的な抗体
US10358493B2 (en) Bispecific format suitable for use in high-through-put screening
US10677787B2 (en) Antibody screening methods
Peng et al. Mining naive rabbit antibody repertoires by phage display for monoclonal antibodies of therapeutic utility
US12247075B2 (en) BTN3A binding proteins and uses thereof
US11332522B2 (en) Modified variable domain molecules and methods for producing them
US20160145328A1 (en) Modified Variable Domain Molecules And Methods For Producing And Using Same
CN107955071A (zh) 人源抗人cd47抗体及其编码基因与应用
JP2009511892A (ja) 抗体ポリペプチドライブラリーのスクリーニングと選択された抗体ポリペプチド
WO2018050027A1 (zh) 一种能够特异性地结合pd-1的抗体及其功能片段
US20080003617A1 (en) Methods for the identification and the isolation of epitope specific antibodies
WO2022037527A1 (zh) 结合bcma的单可变结构域及抗原结合分子
Sandeep et al. Engineered polyspecific antibodies: A new frontier in the field of immunotherapeutics
JP2009508521A5 (https=)
JP6918399B2 (ja) 抗体ナイーブライブラリーを生成する方法、前記ライブラリー及びその用途
US20170306039A1 (en) Human vh domain scaffolds
JP2012232948A5 (https=)
Lai et al. Synthetic Antibody Engineering: Concepts and Applications